in the case of GATC Health Wrap up Investor overview presentation PDF GATC ... REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED ... in 2018, you'll see that we have a huge head start on some of our larger ...
person in 2018. With the United States Population estimated to be 332.6 ... on energy in 2018 alone. There were an estimated 141.95 Million homes ... A SmartGreen™ Home project manager will assess site conditions including envelope ...
Earn an annual dividend of 8%, paid monthly. Minimum investment $10,000
their Offering Circular HERE. InSitu Biologics InSitu Biologics is an emerging ... overdose. InSitu is focused on providing a solution to these problems. InSitu has ...
View our Offering Circular HERE. InSitu Biologics- AnestaGel™ InSitu ... AnestaGel™, a long-acting non-opiate painkiller. Insitu has raised $2.57 million ... an increased share price for their offering. Their InSitu Reg A+ offering ...
2018, which is kind of the Genesis of this call, right? So, Regulation A ... the end of 2018. We'll be updating those from media 2019 in the coming ... Regulation A+ in total through the end of 2018. Excuse me, the majority ...
7:00PM Networking EXPERTS: Jim Segermark | Host; CEO, InSitu Biologics; ... About InSitu Biologics InSitu Biologics is an emerging biotech company, ... Segermark, CEO of InSitu Biologics 1-651-338-4801 | [email protected] ...
a maximum of $30 mill. InSitu Biologics InSitu Biologics is an emerging ... overdose. InSitu is focused on providing a solution to these problems. InSitu has ...
to be approved by the Swiss Regulators. CHECK OUT TALKETH HERE. InSitu Bi ... is in the early stages of an annual $90 billion market opportunity. InSitu Biologics ... OUT INSITU BIOLOGICS HERE. View their Offering Circular HERE ...
have shut down their higher risk categories because of defaults ... you may see some defaults with the, with the larger wirehouses. ... other things. What about defaults? I suppose you're saying ...
